APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy CRO Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cell and Gene Therapy CRO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026193 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy CRO Service Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy CRO Service Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy CRO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy CRO Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy CRO Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Cell and Gene Therapy CRO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cell and Gene Therapy CRO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell and Gene Therapy CRO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell and Gene Therapy CRO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cell and Gene Therapy CRO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cell and Gene Therapy CRO Service include PPD, Medpace, Labcorp, Veristat, Charles River Laboratories, Premier Research, Catalent, IQVIA and Vial, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cell and Gene Therapy CRO Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell and Gene Therapy CRO Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell and Gene Therapy CRO Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cell and Gene Therapy CRO Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Cell and Gene Therapy CRO Service Segment by Company

PPD

Medpace

Labcorp

Veristat

Charles River Laboratories

Premier Research

Catalent

IQVIA

Vial

Noble Life Sciences

Ergomed

Cell and Gene Therapy CRO Service Segment by Type

Preclinical CRO

Clinical Stage CRO

Others

Cell and Gene Therapy CRO Service Segment by Application

Hospital

Research Institute

Others

Cell and Gene Therapy CRO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy CRO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy CRO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy CRO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell and Gene Therapy CRO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell and Gene Therapy CRO Service industry.

Chapter 3: Detailed analysis of Cell and Gene Therapy CRO Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell and Gene Therapy CRO Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy CRO Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Preclinical CRO Table 3. Key Players of Clinical Stage CRO Table 4. Key Players of Others Table 4. Global Cell and Gene Therapy CRO Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Research Institute Table 7. Key Players of Others Table 8. Global Cell and Gene Therapy CRO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Cell and Gene Therapy CRO Service Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Cell and Gene Therapy CRO Service Market Share by Region (2021-2026) Table 11. Global Cell and Gene Therapy CRO Service Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Cell and Gene Therapy CRO Service Market Share by Region (2027-2032) Table 13. Cell and Gene Therapy CRO Service Industry Trends Table 14. Cell and Gene Therapy CRO Service Industry Drivers Table 15. Cell and Gene Therapy CRO Service Industry Opportunities and Challenges Table 16. Cell and Gene Therapy CRO Service Industry Restraints Table 17. Global Cell and Gene Therapy CRO Service Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Cell and Gene Therapy CRO Service Revenue Market Share by Company (2021-2026) Table 19. Global Cell and Gene Therapy CRO Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Cell and Gene Therapy CRO Service Key Company Head Office and Area Served Table 21. Global Cell and Gene Therapy CRO Service Company, Product Type & Application Table 22. Global Cell and Gene Therapy CRO Service Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Cell and Gene Therapy CRO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Cell and Gene Therapy CRO Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cell and Gene Therapy CRO Service Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Cell and Gene Therapy CRO Service Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Cell and Gene Therapy CRO Service Revenue Market Share by Type (2021-2026) Table 29. Global Cell and Gene Therapy CRO Service Revenue Market Share by Type (2027-2032) Table 30. Global Cell and Gene Therapy CRO Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cell and Gene Therapy CRO Service Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Cell and Gene Therapy CRO Service Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Cell and Gene Therapy CRO Service Revenue Market Share by Application (2021-2026) Table 34. Global Cell and Gene Therapy CRO Service Revenue Market Share by Application (2027-2032) Table 35. PPD Company Information Table 36. PPD Business Overview Table 37. PPD Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. PPD Cell and Gene Therapy CRO Service Product Portfolio Table 39. PPD Recent Development Table 40. Medpace Company Information Table 41. Medpace Business Overview Table 42. Medpace Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Medpace Cell and Gene Therapy CRO Service Product Portfolio Table 44. Medpace Recent Development Table 45. Labcorp Company Information Table 46. Labcorp Business Overview Table 47. Labcorp Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Labcorp Cell and Gene Therapy CRO Service Product Portfolio Table 49. Labcorp Recent Development Table 50. Veristat Company Information Table 51. Veristat Business Overview Table 52. Veristat Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Veristat Cell and Gene Therapy CRO Service Product Portfolio Table 54. Veristat Recent Development Table 55. Charles River Laboratories Company Information Table 56. Charles River Laboratories Business Overview Table 57. Charles River Laboratories Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Charles River Laboratories Cell and Gene Therapy CRO Service Product Portfolio Table 59. Charles River Laboratories Recent Development Table 60. Premier Research Company Information Table 61. Premier Research Business Overview Table 62. Premier Research Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Premier Research Cell and Gene Therapy CRO Service Product Portfolio Table 64. Premier Research Recent Development Table 65. Catalent Company Information Table 66. Catalent Business Overview Table 67. Catalent Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Catalent Cell and Gene Therapy CRO Service Product Portfolio Table 69. Catalent Recent Development Table 70. IQVIA Company Information Table 71. IQVIA Business Overview Table 72. IQVIA Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. IQVIA Cell and Gene Therapy CRO Service Product Portfolio Table 74. IQVIA Recent Development Table 75. Vial Company Information Table 76. Vial Business Overview Table 77. Vial Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Vial Cell and Gene Therapy CRO Service Product Portfolio Table 79. Vial Recent Development Table 80. Noble Life Sciences Company Information Table 81. Noble Life Sciences Business Overview Table 82. Noble Life Sciences Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Noble Life Sciences Cell and Gene Therapy CRO Service Product Portfolio Table 84. Noble Life Sciences Recent Development Table 85. Ergomed Company Information Table 86. Ergomed Business Overview Table 87. Ergomed Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Ergomed Cell and Gene Therapy CRO Service Product Portfolio Table 89. Ergomed Recent Development Table 90. North America Cell and Gene Therapy CRO Service Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Cell and Gene Therapy CRO Service Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Cell and Gene Therapy CRO Service Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Cell and Gene Therapy CRO Service Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Cell and Gene Therapy CRO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Cell and Gene Therapy CRO Service Market Size by Country (2021-2026) Table 96. North America Cell and Gene Therapy CRO Service Market Size by Country (2027-2032) Table 97. Europe Cell and Gene Therapy CRO Service Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Cell and Gene Therapy CRO Service Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Cell and Gene Therapy CRO Service Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Cell and Gene Therapy CRO Service Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Cell and Gene Therapy CRO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Cell and Gene Therapy CRO Service Market Size by Country (2021-2026) Table 103. Europe Cell and Gene Therapy CRO Service Market Size by Country (2027-2032) Table 104. China Cell and Gene Therapy CRO Service Market Size by Type (2021-2026) & (US$ Million) Table 105. China Cell and Gene Therapy CRO Service Market Size by Type (2027-2032) & (US$ Million) Table 106. China Cell and Gene Therapy CRO Service Market Size by Application (2021-2026) & (US$ Million) Table 107. China Cell and Gene Therapy CRO Service Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Cell and Gene Therapy CRO Service Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Cell and Gene Therapy CRO Service Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Cell and Gene Therapy CRO Service Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Cell and Gene Therapy CRO Service Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Cell and Gene Therapy CRO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Cell and Gene Therapy CRO Service Market Size by Country (2021-2026) Table 114. Asia Cell and Gene Therapy CRO Service Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Cell and Gene Therapy CRO Service Product Image Figure 2. Global Cell and Gene Therapy CRO Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cell and Gene Therapy CRO Service Market Share by Type: 2025 VS 2032 Figure 4. Preclinical CRO Image Figure 5. Clinical Stage CRO Image Figure 6. Others Image Figure 7. Global Cell and Gene Therapy CRO Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Cell and Gene Therapy CRO Service Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Research Institute Image Figure 11. Others Image Figure 12. Global Cell and Gene Therapy CRO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 14. Global Cell and Gene Therapy CRO Service Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Cell and Gene Therapy CRO Service Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Cell and Gene Therapy CRO Service Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cell and Gene Therapy CRO Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cell and Gene Therapy CRO Service Revenue Market Share by Type (2021-2032) Figure 21. Global Cell and Gene Therapy CRO Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Cell and Gene Therapy CRO Service Revenue Market Share by Application (2021-2032) Figure 23. North America Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 24. North America Cell and Gene Therapy CRO Service Market Share by Type (2021-2032) Figure 25. North America Cell and Gene Therapy CRO Service Market Share by Application (2021-2032) Figure 26. North America Cell and Gene Therapy CRO Service Market Share by Country (2021-2032) Figure 27. United States Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 28. Canada Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 30. Europe Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe Cell and Gene Therapy CRO Service Market Share by Type (2021-2032) Figure 32. Europe Cell and Gene Therapy CRO Service Market Share by Application (2021-2032) Figure 33. Europe Cell and Gene Therapy CRO Service Market Share by Country (2021-2032) Figure 34. Germany Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 35. France Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 37. Italy Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 38. Russia Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 40. China Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 41. China Cell and Gene Therapy CRO Service Market Share by Type (2021-2032) Figure 42. China Cell and Gene Therapy CRO Service Market Share by Application (2021-2032) Figure 43. Asia Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 44. Asia Cell and Gene Therapy CRO Service Market Share by Type (2021-2032) Figure 45. Asia Cell and Gene Therapy CRO Service Market Share by Application (2021-2032) Figure 46. Asia Cell and Gene Therapy CRO Service Market Share by Country (2021-2032) Figure 47. Japan Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 51. India Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 52. Australia Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Share by Country (2021-2032) Figure 57. Brazil Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 62. UAE Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 64. Chile Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical CRO
  • Clinical Stage CRO
  • Others
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • PPD
  • Medpace
  • Labcorp
  • Veristat
  • Charles River Laboratories
  • Premier Research
  • Catalent
  • IQVIA
  • Vial
  • Noble Life Sciences
  • Ergomed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cell and Gene Therapy CRO Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Preclinical CRO
  5. 1.2.3 Clinical Stage CRO
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Cell and Gene Therapy CRO Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Research Institute
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Cell and Gene Therapy CRO Service Growth Trends by Region
  14. 1.5.1 Global Cell and Gene Therapy CRO Service Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Cell and Gene Therapy CRO Service Market Size by Region (2021-2026)
  16. 1.5.3 Cell and Gene Therapy CRO Service Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Cell and Gene Therapy CRO Service Market Dynamics
  1. 2.1 Cell and Gene Therapy CRO Service Industry Trends
  2. 2.2 Cell and Gene Therapy CRO Service Industry Drivers
  3. 2.3 Cell and Gene Therapy CRO Service Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy CRO Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cell and Gene Therapy CRO Service Revenue by Company (2021-2026)
  2. 3.2 Global Cell and Gene Therapy CRO Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cell and Gene Therapy CRO Service Key Company Head office and Area Served
  4. 3.4 Global Cell and Gene Therapy CRO Service Company, Product Type & Application
  5. 3.5 Global Cell and Gene Therapy CRO Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cell and Gene Therapy CRO Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cell and Gene Therapy CRO Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cell and Gene Therapy CRO Service Tier 1, Tier 2, and Tier 3
4 Cell and Gene Therapy CRO Service Market by Type
  1. 4.1 Global Cell and Gene Therapy CRO Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cell and Gene Therapy CRO Service Market Size by Type (2021-2032)
  3. 4.3 Global Cell and Gene Therapy CRO Service Market Size Share by Type (2021-2032)
5 Cell and Gene Therapy CRO Service Market by Application
  1. 5.1 Global Cell and Gene Therapy CRO Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell and Gene Therapy CRO Service Market Size by Application (2021-2032)
  3. 5.3 Global Cell and Gene Therapy CRO Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 PPD
  2. 6.1.1 PPD Company Information
  3. 6.1.2 PPD Business Overview
  4. 6.1.3 PPD Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 PPD Cell and Gene Therapy CRO Service Product Portfolio
  6. 6.1.5 PPD Recent Developments
  7. 6.2 Medpace
  8. 6.2.1 Medpace Company Information
  9. 6.2.2 Medpace Business Overview
  10. 6.2.3 Medpace Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Medpace Cell and Gene Therapy CRO Service Product Portfolio
  12. 6.2.5 Medpace Recent Developments
  13. 6.3 Labcorp
  14. 6.3.1 Labcorp Company Information
  15. 6.3.2 Labcorp Business Overview
  16. 6.3.3 Labcorp Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Labcorp Cell and Gene Therapy CRO Service Product Portfolio
  18. 6.3.5 Labcorp Recent Developments
  19. 6.4 Veristat
  20. 6.4.1 Veristat Company Information
  21. 6.4.2 Veristat Business Overview
  22. 6.4.3 Veristat Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Veristat Cell and Gene Therapy CRO Service Product Portfolio
  24. 6.4.5 Veristat Recent Developments
  25. 6.5 Charles River Laboratories
  26. 6.5.1 Charles River Laboratories Company Information
  27. 6.5.2 Charles River Laboratories Business Overview
  28. 6.5.3 Charles River Laboratories Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Charles River Laboratories Cell and Gene Therapy CRO Service Product Portfolio
  30. 6.5.5 Charles River Laboratories Recent Developments
  31. 6.6 Premier Research
  32. 6.6.1 Premier Research Company Information
  33. 6.6.2 Premier Research Business Overview
  34. 6.6.3 Premier Research Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Premier Research Cell and Gene Therapy CRO Service Product Portfolio
  36. 6.6.5 Premier Research Recent Developments
  37. 6.7 Catalent
  38. 6.7.1 Catalent Company Information
  39. 6.7.2 Catalent Business Overview
  40. 6.7.3 Catalent Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Catalent Cell and Gene Therapy CRO Service Product Portfolio
  42. 6.7.5 Catalent Recent Developments
  43. 6.8 IQVIA
  44. 6.8.1 IQVIA Company Information
  45. 6.8.2 IQVIA Business Overview
  46. 6.8.3 IQVIA Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 IQVIA Cell and Gene Therapy CRO Service Product Portfolio
  48. 6.8.5 IQVIA Recent Developments
  49. 6.9 Vial
  50. 6.9.1 Vial Company Information
  51. 6.9.2 Vial Business Overview
  52. 6.9.3 Vial Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Vial Cell and Gene Therapy CRO Service Product Portfolio
  54. 6.9.5 Vial Recent Developments
  55. 6.10 Noble Life Sciences
  56. 6.10.1 Noble Life Sciences Company Information
  57. 6.10.2 Noble Life Sciences Business Overview
  58. 6.10.3 Noble Life Sciences Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Noble Life Sciences Cell and Gene Therapy CRO Service Product Portfolio
  60. 6.10.5 Noble Life Sciences Recent Developments
  61. 6.11 Ergomed
  62. 6.11.1 Ergomed Company Information
  63. 6.11.2 Ergomed Business Overview
  64. 6.11.3 Ergomed Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Ergomed Cell and Gene Therapy CRO Service Product Portfolio
  66. 6.11.5 Ergomed Recent Developments
7 North America
  1. 7.1 North America Cell and Gene Therapy CRO Service Market Size (2021-2032)
  2. 7.2 North America Cell and Gene Therapy CRO Service Market Size by Type
  3. 7.2.1 North America Cell and Gene Therapy CRO Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Cell and Gene Therapy CRO Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Cell and Gene Therapy CRO Service Market Share by Type (2021-2032)
  6. 7.3 North America Cell and Gene Therapy CRO Service Market Size by Application
  7. 7.3.1 North America Cell and Gene Therapy CRO Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Cell and Gene Therapy CRO Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Cell and Gene Therapy CRO Service Market Share by Application (2021-2032)
  10. 7.4 North America Cell and Gene Therapy CRO Service Market Size by Country
  11. 7.4.1 North America Cell and Gene Therapy CRO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cell and Gene Therapy CRO Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Cell and Gene Therapy CRO Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Cell and Gene Therapy CRO Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cell and Gene Therapy CRO Service Market Size (2021-2032)
  2. 8.2 Europe Cell and Gene Therapy CRO Service Market Size by Type
  3. 8.2.1 Europe Cell and Gene Therapy CRO Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cell and Gene Therapy CRO Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cell and Gene Therapy CRO Service Market Share by Type (2021-2032)
  6. 8.3 Europe Cell and Gene Therapy CRO Service Market Size by Application
  7. 8.3.1 Europe Cell and Gene Therapy CRO Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cell and Gene Therapy CRO Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cell and Gene Therapy CRO Service Market Share by Application (2021-2032)
  10. 8.4 Europe Cell and Gene Therapy CRO Service Market Size by Country
  11. 8.4.1 Europe Cell and Gene Therapy CRO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cell and Gene Therapy CRO Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cell and Gene Therapy CRO Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cell and Gene Therapy CRO Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cell and Gene Therapy CRO Service Market Size (2021-2032)
  2. 9.2 China Cell and Gene Therapy CRO Service Market Size by Type
  3. 9.2.1 China Cell and Gene Therapy CRO Service Market Size by Type (2021-2026)
  4. 9.2.2 China Cell and Gene Therapy CRO Service Market Size by Type (2027-2032)
  5. 9.2.3 China Cell and Gene Therapy CRO Service Market Share by Type (2021-2032)
  6. 9.3 China Cell and Gene Therapy CRO Service Market Size by Application
  7. 9.3.1 China Cell and Gene Therapy CRO Service Market Size by Application (2021-2026)
  8. 9.3.2 China Cell and Gene Therapy CRO Service Market Size by Application (2027-2032)
  9. 9.3.3 China Cell and Gene Therapy CRO Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cell and Gene Therapy CRO Service Market Size (2021-2032)
  2. 10.2 Asia Cell and Gene Therapy CRO Service Market Size by Type
  3. 10.2.1 Asia Cell and Gene Therapy CRO Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cell and Gene Therapy CRO Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cell and Gene Therapy CRO Service Market Share by Type (2021-2032)
  6. 10.3 Asia Cell and Gene Therapy CRO Service Market Size by Application
  7. 10.3.1 Asia Cell and Gene Therapy CRO Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cell and Gene Therapy CRO Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cell and Gene Therapy CRO Service Market Share by Application (2021-2032)
  10. 10.4 Asia Cell and Gene Therapy CRO Service Market Size by Country
  11. 10.4.1 Asia Cell and Gene Therapy CRO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cell and Gene Therapy CRO Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cell and Gene Therapy CRO Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cell and Gene Therapy CRO Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cell and Gene Therapy CRO Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst